• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Nonalcoholic fatty liver disease.

作者信息

Clark Jeanne M, Brancati Frederick L, Diehl Anna Mae

机构信息

Department of Medicine, The Johns Hopkins University, 720 Rutland Street, Baltimore, MD 21205, USA.

出版信息

Gastroenterology. 2002 May;122(6):1649-57. doi: 10.1053/gast.2002.33573.

DOI:10.1053/gast.2002.33573
PMID:12016429
Abstract
摘要

相似文献

1
Nonalcoholic fatty liver disease.非酒精性脂肪性肝病
Gastroenterology. 2002 May;122(6):1649-57. doi: 10.1053/gast.2002.33573.
2
AGA technical review on nonalcoholic fatty liver disease.美国胃肠病学会关于非酒精性脂肪性肝病的技术审查
Gastroenterology. 2002 Nov;123(5):1705-25. doi: 10.1053/gast.2002.36572.
3
Nonalcoholic fatty liver disease.非酒精性脂肪性肝病
N Engl J Med. 2002 Apr 18;346(16):1221-31. doi: 10.1056/NEJMra011775.
4
Nonalcoholic fatty liver disease: is all the fat bad?非酒精性脂肪性肝病：所有的脂肪都有害吗？
Intern Med J. 2004 Apr;34(4):187-91. doi: 10.1111/j.1444-0903.2004.00574.x.
5
Nonalcoholic fatty liver disease in pediatric patients.儿童非酒精性脂肪性肝病。
JPEN J Parenter Enteral Nutr. 2012 Jan;36(1 Suppl):43S-8S. doi: 10.1177/0148607111421610.
6
Nonalcoholic fatty liver disease.非酒精性脂肪性肝病
Am Fam Physician. 2013 Jul 1;88(1):Online.
7
Approach to the diagnosis and treatment of nonalcoholic fatty liver disease.非酒精性脂肪性肝病的诊断与治疗方法
Clin Liver Dis. 2005 Nov;9(4):617-34, vi. doi: 10.1016/j.cld.2005.07.002.
8
Nonalcoholic fatty liver disease.非酒精性脂肪性肝病
CMAJ. 2005 Mar 29;172(7):899-905. doi: 10.1503/cmaj.045232.
9
Nonalcoholic fatty liver disease of obesity.肥胖相关性非酒精性脂肪性肝病
Obes Surg. 2006 Nov;16(11):1412-9. doi: 10.1381/096089206778870012.
10
[Current knowledge of nonalcoholic steatohepatitis].
Med Clin (Barc). 2003 Jun 21;121(3):102-8. doi: 10.1016/s0025-7753(03)73870-6.

引用本文的文献

1
Sex differences in metabolic dysfunction-associated steatotic liver disease: a narrative review.代谢功能障碍相关脂肪性肝病中的性别差异：一项叙述性综述。
Ewha Med J. 2024 Apr;47(2):e17. doi: 10.12771/emj.2024.e17. Epub 2024 Apr 30.
2
Free fatty acid-induced miR-22 inhibits gluconeogenesis via SIRT-1-mediated PGC-1α expression in nonalcoholic fatty liver disease.游离脂肪酸诱导的miR-22通过SIRT-1介导的PGC-1α表达抑制非酒精性脂肪性肝病中的糖异生。
ILIVER. 2023 Feb 7;2(1):1-9. doi: 10.1016/j.iliver.2023.01.002. eCollection 2023 Mar.
3
Molecular Mechanisms, Endurance Athlete, and Synergistic Therapeutic Effects of Marine-Derived Antioxidant Astaxanthin Supplementation and Exercise in Cancer, Metabolic Diseases, and Healthy Individuals.
海洋来源的抗氧化剂虾青素补充剂与运动在癌症、代谢性疾病及健康个体中的分子机制、耐力运动员及协同治疗作用
Food Sci Nutr. 2025 Jun 27;13(7):e70470. doi: 10.1002/fsn3.70470. eCollection 2025 Jul.
4
Loss of ovarian function prevents exercise-induced activation of hepatic mitophagic flux.卵巢功能丧失会阻止运动诱导的肝脏线粒体自噬通量的激活。
Am J Physiol Endocrinol Metab. 2025 Jun 1;328(6):E869-E884. doi: 10.1152/ajpendo.00107.2025. Epub 2025 Apr 28.
5
Are alterations needed in Silybum marianum (Silymarin) administration practices? A novel outlook and meta-analysis on randomized trials targeting liver injury.水飞蓟（水飞蓟素）的给药方法是否需要改变？针对肝损伤的随机试验的新观点和荟萃分析。
BMC Complement Med Ther. 2025 Apr 12;25(1):134. doi: 10.1186/s12906-025-04886-y.
6
Expression Analysis of Circulating miR-21, miR-34a and miR-122 and Redox Status Markers in Metabolic Dysfunction-Associated Steatotic Liver Disease Patients with and Without Type 2 Diabetes.伴有和不伴有2型糖尿病的代谢功能障碍相关脂肪性肝病患者循环miR-21、miR-34a和miR-122及氧化还原状态标志物的表达分析
Int J Mol Sci. 2025 Mar 7;26(6):2392. doi: 10.3390/ijms26062392.
7
Hepatic Satellite Cell Activation and Alteration of Vitamin A Status Are Relevant to the Aggravation of Retinopathy by T2DM.肝星状细胞激活和维生素A状态改变与2型糖尿病加重视网膜病变有关。
Invest Ophthalmol Vis Sci. 2025 Feb 3;66(2):7. doi: 10.1167/iovs.66.2.7.
8
Quantitative contrast-enhanced ultrasonography in the diagnosis and grading of hepatic steatosis in brain-dead donors.定量对比增强超声在脑死亡供体肝脂肪变性诊断及分级中的应用
Quant Imaging Med Surg. 2025 Jan 2;15(1):326-338. doi: 10.21037/qims-24-1004. Epub 2024 Dec 16.
9
Hormone replacement therapy for steatotic liver management after surgical menopause.手术绝经后脂肪性肝病管理的激素替代疗法。
Clin J Gastroenterol. 2025 Apr;18(2):352-356. doi: 10.1007/s12328-024-02090-y. Epub 2025 Jan 6.
10
Sex Hormone: A Potential Target at Treating Female Metabolic Dysfunction-Associated Steatotic Liver Disease?性激素：治疗女性代谢功能障碍相关脂肪性肝病的潜在靶点？
J Clin Exp Hepatol. 2025 Mar-Apr;15(2):102459. doi: 10.1016/j.jceh.2024.102459. Epub 2024 Nov 19.